JRPIM
REGN icon

Journey Retirement Planning & Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Journey Retirement Planning & Investment Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$672K Sell
1,077
-52
-5% -$35.4K 0.52% 59
2026
Q1 		$873K Sell
1,129
-3,211
-74% -$2.46M 0.77% 38
2025
Q4 		$3.35M Buy
+4,340
New +$2.95M 0.69% 31

Other funds holding REGN

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Journey Retirement Planning & Investment Management's REGN Position: Q2 2026 in Review

Journey Retirement Planning & Investment Management reduced its Regeneron Pharmaceuticals (REGN) stake by 4.6% in Q2 2026, selling an estimated $35.4K and leaving 1,077 shares worth $672K. The position accounts for 0.52% of the portfolio, ranked #59.

Journey Retirement Planning & Investment Management first reported a position in REGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.35M in Q4 2025. 676 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Journey Retirement Planning & Investment Management held 1,077 shares of Regeneron Pharmaceuticals worth $672K as of Q2 2026.
  • Journey Retirement Planning & Investment Management sold 52 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $35.4K.
  • Regeneron Pharmaceuticals made up 0.52% of Journey Retirement Planning & Investment Management's portfolio in Q2 2026, its #59 holding.
  • Journey Retirement Planning & Investment Management first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Journey Retirement Planning & Investment Management's Regeneron Pharmaceuticals position peaked at $3.35M in Q4 2025.
  • 676 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Journey Retirement Planning & Investment Management's 13F filing for Q2 2026, filed 24 Jul 2026.